Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

77
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
77
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

347
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
347
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

373
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
373
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

738
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
738
Guidelines for Nursing Documentation I01:30

Guidelines for Nursing Documentation I

2.6K
Quality documentation and reporting share essential characteristics that ensure they are practical and valuable resources for those who use them. These characteristics are:
Factual:  
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
2.6K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

3.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-Effectiveness of Tezepelumab Versus Omalizumab in Patients with Severe Uncontrolled Allergic Asthma in Spain.

PharmacoEconomics - open·2026
Same author

Rescue Inhaler Overuse in Severe Asthma: A Real-World Study of Short-Acting β<sub>2</sub>-Agonist and Short-Acting Muscarinic Antagonist Use.

Biomedicines·2026
Same author

Real-World Effectiveness of Tezepelumab Across T2 and Non-T2 Severe Asthma Phenotypes: A Multicenter Spanish Cohort Study.

Archivos de bronconeumologia·2026
Same author

Inhalers and climate change: A sustainable approach to severe asthma management.

Respiratory medicine·2026
Same author

Severe Asthma in Women: Clinical Characteristics and Pharmacological Implications for Tailored Management.

Respiration; international review of thoracic diseases·2026
Same author

Tezepelumab in Allergic Bronchopulmonary Aspergillosis With Severe Uncontrolled Asthma: A Retrospective 4-Case Series.

Journal of investigational allergology & clinical immunology·2026
Same journal

Dual biologics or combination therapy with small molecules in pediatric inflammatory bowel disease: a systematic review and meta-analysis.

World journal of pediatrics : WJP·2026
Same journal

Diaphragm in sudden unexpected infant and fetal death.

World journal of pediatrics : WJP·2026
Same journal

Behçet's spectrum disorders: genetic and immunological insights into an emerging disease concept.

World journal of pediatrics : WJP·2026
Same journal

Role of CHD chromatin remodelers in heart development.

World journal of pediatrics : WJP·2026
Same journal

Transplantation of encapsulated fecal microbiota: research progress and future trends.

World journal of pediatrics : WJP·2026
Same journal

Pediatric liver transplantation for metabolic diseases: a single-center experience.

World journal of pediatrics : WJP·2026
See all related articles

Related Experiment Video

Updated: Mar 28, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.5K

New technologies as a strategy to decrease medication errors: how do they affect adults and children differently?

Margarita Ruano1, Elena Villamañán2, Ester Pérez2

  • 1Department of Pharmacy, La Paz University Hospital, Madrid, Spain. margarita.ruano@salud.madrid.org.

World Journal of Pediatrics : WJP
|December 20, 2015
PubMed
Summary
This summary is machine-generated.

New technologies like computerized physician order entry (CPOE) can reduce pediatric medication errors. However, careful implementation is crucial to avoid introducing new risks in child healthcare settings.

Keywords:
electronic prescribingnew technologiespediatric medication errors

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.4K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

Related Experiment Videos

Last Updated: Mar 28, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.5K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.4K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K

Area of Science:

  • Pediatric pharmacology
  • Health informatics
  • Patient safety

Background:

  • Medication errors pose a higher risk of severe adverse effects and injury in children compared to adults.
  • Pediatric medication errors are particularly significant due to children's unique risk factors and physiological differences.
  • Errors commonly occur during the prescribing and administration phases of drug treatment.

Purpose of the Study:

  • To review available data on new technologies aimed at reducing medication errors in pediatric populations.
  • To assess the effectiveness and potential drawbacks of technological interventions in pediatric patient safety.

Main Methods:

  • Literature review of published data on new technologies for reducing pediatric medication errors.
  • Analysis of studies focusing on computerized physician order entry (CPOE) and decision-support platforms.

Main Results:

  • New technologies, particularly CPOE and decision-support systems, have demonstrated effectiveness in reducing medication errors.
  • Despite benefits, the implementation of these informatics tools can introduce novel types of errors.
  • A lack of standardized definitions and terminology complicates comparative analysis across studies.

Conclusions:

  • Prioritizing the implementation of CPOE programs in pediatric care is essential for enhancing patient safety.
  • Improving communication among healthcare professionals involved in the care of hospitalized children is a key priority.
  • Increased knowledge and understanding of these technological programs among healthcare providers are crucial for safe and effective use.